Definium Therapeutics Inc.
DFTX | NASDAQ
$36.33
-$1.63 (-4.29%)
At close: Oct 30, 2026, 4:00 PM ET
$36.33
$0.00 (0.00%)
Pre-market:
Nov 2, 2026, 8:23 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 527K | 3.16M | n/a | n/a | n/a |
Gross Profit | n/a | -527K | -3.16M | n/a | n/a | n/a |
Operating Income | -166.31M | -103.92M | -93.87M | -66.33M | -93.85M | -33.03M |
Interest Income | 10.96M | 11.56M | 5.58M | 1.5M | n/a | n/a |
Pretax Income | -183.79M | -108.68M | -95.73M | -56.8M | -94.19M | -33.94M |
Net Income | -183.79M | -108.68M | -95.73M | -56.8M | -93.04M | -34.1M |
Selling & General & Admin | 48.64M | 38.62M | 41.74M | 30.16M | 59.07M | 14.4M |
Research & Development | 117.67M | 65.3M | 48.96M | 36.17M | 34.79M | 18.63M |
Other Expenses | n/a | -527K | n/a | n/a | n/a | n/a |
Operating Expenses | 166.31M | 103.39M | 90.7M | 66.33M | 93.85M | 33.03M |
Interest Expense | 5.48M | 2.28M | 920K | 1.5M | 359K | 164K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 166.31M | 103.92M | 93.87M | 66.33M | 93.85M | 33.03M |
Income Tax Expense | n/a | n/a | n/a | n/a | -1.16M | n/a |
Shares Outstanding (Basic) | 89.33M | 70.46M | 39.16M | 30.86M | 27.38M | 17.75M |
Shares Outstanding (Diluted) | 89.33M | 704.61M | 39.16M | 30.86M | 27.38M | 17.75M |
EPS (Basic) | -2.06 | -1.54 | -2.44 | -1.53 | -3.40 | -1.92 |
EPS (Diluted) | -2.06 | -0.15 | -2.44 | -1.53 | -3.40 | -1.92 |
EBITDA | -178.31M | -105.87M | -92.57M | -52.12M | -91.22M | -33.57M |
EBIT | -178.31M | -106.4M | -95.73M | -55.3M | -93.83M | -33.77M |
Depreciation & Amortization | n/a | 527K | 3.16M | 3.18M | 2.62M | 206.3K |
Add to Watchlist
Select watchlists to add or remove DFTX